Relief for J&J: Supreme court closes faulty hip implants case

Published On 2019-01-11 04:30 GMT   |   Update On 2021-08-16 09:47 GMT


A bench comprising Chief Justice Ranjan Gogoi and Justice S K Kaul considered the response filed by the Union Health Ministry which said that a compensation scheme has been formulated by it to ensure proper compensation to the victims of Johnson and Johnson faulty hip implants.


New Delhi: The Supreme Court Friday closed the case seeking action against US-based pharma major Johnson and Johnson for implanting faulty hip implants into patients here, saying that steps have been taken by the Centre to provide compensation up to Rs 1.22 crore to them. A bench comprising Chief Justice Ranjan Gogoi and Justice S K Kaul considered the response filed by the Union Health Ministry which said that a compensation scheme has been formulated by it to ensure proper compensation to the victims of faulty hip implants.




Disposing of the PIL filed by one Arun Goenka, the top court asked the Centre to widely publicise its compensation scheme to ensure that all the victims of such implants seek help for their grievances.



Earlier, the Centre had informed the apex court that the report of its panel on alleged "faulty" hip implants, made by the pharma major was ready and would be filed within a week. The PIL had alleged that "faulty" and "deadly" hip implants have been fitted into the bodies of 4,525 Indian patients who had undergone the replacement surgeries since 2005.


Also Read: Faulty Implant: J&J launches IPAP Reimbursement Programme


Tags:    
Article Source : With input

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News